Optiscan Imaging Ltd (OIL) - Total Assets
Based on the latest financial reports, Optiscan Imaging Ltd (OIL) holds total assets worth AU$10.56 Million AUD (≈ $7.47 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See OIL net assets for net asset value and shareholders' equity analysis.
Optiscan Imaging Ltd - Total Assets Trend (1998–2025)
This chart illustrates how Optiscan Imaging Ltd's total assets have evolved over time, based on quarterly financial data.
Optiscan Imaging Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Optiscan Imaging Ltd's total assets of AU$10.56 Million consist of 84.0% current assets and 16.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$4.55 Million | 43.1% |
| Accounts Receivable | AU$316.55K | 3.0% |
| Inventory | AU$1.67 Million | 15.9% |
| Property, Plant & Equipment | AU$1.69 Million | 16.0% |
| Intangible Assets | AU$4.70K | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1998–2025)
This chart illustrates how Optiscan Imaging Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Optiscan Imaging Ltd worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Optiscan Imaging Ltd's current assets represent 84.0% of total assets in 2025, an increase from 26.1% in 1998.
- Cash Position: Cash and equivalents constituted 43.1% of total assets in 2025, up from 22.8% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 142.0% in 1998.
- Asset Diversification: The largest asset category is cash and equivalents at 43.1% of total assets.
Optiscan Imaging Ltd Competitors by Total Assets
Key competitors of Optiscan Imaging Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Everbest Machinery Indus
SHE:002980
|
China | CN¥1.46 Billion |
|
Goldcard High-Tech Co Ltd
SHE:300349
|
China | CN¥7.07 Billion |
|
Orexplore Technologies Ltd
AU:OXT
|
Australia | AU$10.11 Million |
|
Codan Ltd
AU:CDA
|
Australia | AU$904.80 Million |
|
Catapult Group International Ltd
AU:CAT
|
Australia | AU$218.31 Million |
|
Ikegps Group Ltd
AU:IKE
|
Australia | AU$51.01 Million |
|
Structural Monitoring Systems Plc
AU:SMN
|
Australia | AU$34.67 Million |
|
Dorsavi Ltd
AU:DVL
|
Australia | AU$3.97 Million |
Optiscan Imaging Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.87 | 8.59 | 2.02 |
| Quick Ratio | 4.76 | 7.45 | 1.09 |
| Cash Ratio | 3.02 | 3.48 | 0.42 |
| Working Capital | AU$7.35 Million | AU$13.31 Million | AU$1.26 Million |
Optiscan Imaging Ltd - Advanced Valuation Insights
This section examines the relationship between Optiscan Imaging Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.51 |
| Latest Market Cap to Assets Ratio | 7.70 |
| Asset Growth Rate (YoY) | -32.5% |
| Total Assets | AU$10.56 Million |
| Market Capitalization | $81.27 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Optiscan Imaging Ltd's assets at a significant premium (7.70x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Optiscan Imaging Ltd's assets decreased by 32.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Optiscan Imaging Ltd (1998–2025)
The table below shows the annual total assets of Optiscan Imaging Ltd from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$10.56 Million ≈ $7.47 Million |
-32.47% |
| 2024-06-30 | AU$15.63 Million ≈ $11.06 Million |
+234.55% |
| 2023-06-30 | AU$4.67 Million ≈ $3.31 Million |
-41.48% |
| 2022-06-30 | AU$7.98 Million ≈ $5.65 Million |
-31.74% |
| 2021-06-30 | AU$11.70 Million ≈ $8.28 Million |
+239.54% |
| 2020-06-30 | AU$3.44 Million ≈ $2.44 Million |
-5.48% |
| 2019-06-30 | AU$3.64 Million ≈ $2.58 Million |
-11.76% |
| 2018-06-30 | AU$4.13 Million ≈ $2.92 Million |
+54.88% |
| 2017-06-30 | AU$2.67 Million ≈ $1.89 Million |
+46.46% |
| 2016-06-30 | AU$1.82 Million ≈ $1.29 Million |
+78.83% |
| 2015-06-30 | AU$1.02 Million ≈ $720.45K |
+24.73% |
| 2014-06-30 | AU$816.35K ≈ $577.62K |
-45.95% |
| 2013-06-30 | AU$1.51 Million ≈ $1.07 Million |
+27.93% |
| 2012-06-30 | AU$1.18 Million ≈ $835.40K |
-46.32% |
| 2011-06-30 | AU$2.20 Million ≈ $1.56 Million |
+0.33% |
| 2010-06-30 | AU$2.19 Million ≈ $1.55 Million |
-23.78% |
| 2009-06-30 | AU$2.88 Million ≈ $2.04 Million |
-68.84% |
| 2008-06-30 | AU$9.23 Million ≈ $6.53 Million |
-20.46% |
| 2007-06-30 | AU$11.60 Million ≈ $8.21 Million |
-3.12% |
| 2006-06-30 | AU$11.98 Million ≈ $8.48 Million |
-16.93% |
| 2005-06-30 | AU$14.42 Million ≈ $10.20 Million |
+5.13% |
| 2004-06-30 | AU$13.72 Million ≈ $9.70 Million |
-29.00% |
| 2003-06-30 | AU$19.32 Million ≈ $13.67 Million |
-12.37% |
| 2002-06-30 | AU$22.04 Million ≈ $15.60 Million |
+61.43% |
| 2001-06-30 | AU$13.66 Million ≈ $9.66 Million |
-25.19% |
| 2000-06-30 | AU$18.25 Million ≈ $12.92 Million |
+127.15% |
| 1999-06-30 | AU$8.04 Million ≈ $5.69 Million |
-4.29% |
| 1998-06-30 | AU$8.40 Million ≈ $5.94 Million |
-- |
About Optiscan Imaging Ltd
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows;… Read more